Capital Asset Advisory Services LLC
Source: SEC Form 13F · as of Mar 2026Capital Asset Advisory Services LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $31.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$31.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 25,018 | $5.8M |
| LLYELI LILLY & Co | 4,845 | $4.5M |
| ABBVAbbVie Inc. | 19,928 | $4.1M |
| ABTABBOTT LABORATORIES | 38,485 | $3.7M |
| PFEPFIZER INC | 115,839 | $3.2M |
| MRKMerck & Co., Inc. | 22,240 | $2.6M |
| BMYBRISTOL MYERS SQUIBB CO | 44,014 | $2.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,697 | $1.8M |
| PMPhilip Morris International Inc | 4,729 | $745K |
| GILDGILEAD SCIENCES, INC. | 3,800 | $516K |
| AMGNAMGEN INC | 1,452 | $509K |
| AZNASTRAZENECA PLC | 2,303 | $462K |
| NVSNovartis AG | 1,697 | $256K |
| ELVElevance Health Inc. | 798 | $255K |
| GMOptec International, Inc. | 2,941 | $237K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 507 | $223K |
| MCKMcKesson Corporation | 255 | $219K |
| SPROSpero Therapeutics, Inc. | 32,548 | $92K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.